Beneski Benjamin Machinas sold ALLO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002057918-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Mar 2, 2026

Published

Mar 4, 2026

Ingested by INSIDER

Nov 5, 04:13 UTC

Last re-read

Nov 5, 04:13 UTC

Extracted facts

Filer

Beneski Benjamin Machinas

Role

SVP, Chief Technical Officer

Transaction

Open-market saleAs filed: “S”

Asset

Allogene Therapeutics, Inc.

Ticker

ALLO

Shares

7,132

Price per share

$2.6

Value

$18,543

Execution date (reported)

Mar 2, 2026

Owned after transaction

203.0K shares

Days from execution to publication

2

Calculation

What this establishes

Beneski Benjamin Machinas filed this Form 4 reporting a open-market sale of ALLO on Mar 2, 2026. It became public on Mar 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

SVP, Chief Technical Officer

Beneski Benjamin Machinascik:0002057918

Issuer

Allogene Therapeutics, Inc.cik:0001737287

Revision history · 0

No field has changed since this record was first ingested.